1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Oral Polio Vaccines (OPV) Revenue
1.4 Market Analysis by Type
1.4.1 Global Oral Polio Vaccines (OPV) Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Trivalent OPV
1.4.3 Bivalent OPV
1.5 Market by Application
1.5.1 Global Oral Polio Vaccines (OPV) Market Share by Application: 2021-2026
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Oral Polio Vaccines (OPV) Market
1.8.1 Global Oral Polio Vaccines (OPV) Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Oral Polio Vaccines (OPV) Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Oral Polio Vaccines (OPV) Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Oral Polio Vaccines (OPV) Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oral Polio Vaccines (OPV) Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Oral Polio Vaccines (OPV) Sales Volume Market Share by Region (2015-2020)
3.2 Global Oral Polio Vaccines (OPV) Sales Revenue Market Share by Region (2015-2020)
3.3 North America Oral Polio Vaccines (OPV) Sales Volume
3.3.1 North America Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.3.2 North America Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Oral Polio Vaccines (OPV) Sales Volume
3.4.1 East Asia Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.5.1 Europe Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.6.1 South Asia Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.7.1 Southeast Asia Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.8.1 Middle East Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.9.1 Africa Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.10.1 Oceania Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.11.1 South America Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.11.2 South America Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Oral Polio Vaccines (OPV) Sales Volume (2015-2020)
3.12.1 Rest of the World Oral Polio Vaccines (OPV) Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Oral Polio Vaccines (OPV) Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Oral Polio Vaccines (OPV) Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Oral Polio Vaccines (OPV) Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Oral Polio Vaccines (OPV) Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Oral Polio Vaccines (OPV) Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Oral Polio Vaccines (OPV) Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Oral Polio Vaccines (OPV) Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Oral Polio Vaccines (OPV) Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Oral Polio Vaccines (OPV) Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Oral Polio Vaccines (OPV) Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Oral Polio Vaccines (OPV) Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Oral Polio Vaccines (OPV) Sales Volume Market Share by Type (2015-2020)
14.2 Global Oral Polio Vaccines (OPV) Sales Revenue Market Share by Type (2015-2020)
14.3 Global Oral Polio Vaccines (OPV) Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Oral Polio Vaccines (OPV) Consumption Volume by Application (2015-2020)
15.2 Global Oral Polio Vaccines (OPV) Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Oral Polio Vaccines (OPV) Business
16.1 Sanofi
16.1.1 Sanofi Company Profile
16.1.2 Sanofi Oral Polio Vaccines (OPV) Product Specification
16.1.3 Sanofi Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Halfkin Bio-Pharmaceuticals
16.2.1 Halfkin Bio-Pharmaceuticals Company Profile
16.2.2 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Specification
16.2.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Serum Institute
16.3.1 Serum Institute Company Profile
16.3.2 Serum Institute Oral Polio Vaccines (OPV) Product Specification
16.3.3 Serum Institute Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 GSK
16.4.1 GSK Company Profile
16.4.2 GSK Oral Polio Vaccines (OPV) Product Specification
16.4.3 GSK Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Bio-Med
16.5.1 Bio-Med Company Profile
16.5.2 Bio-Med Oral Polio Vaccines (OPV) Product Specification
16.5.3 Bio-Med Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Bibcol
16.6.1 Bibcol Company Profile
16.6.2 Bibcol Oral Polio Vaccines (OPV) Product Specification
16.6.3 Bibcol Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Panacea Biotec Ltd
16.7.1 Panacea Biotec Ltd Company Profile
16.7.2 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Specification
16.7.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Tiantan Biological
16.8.1 Tiantan Biological Company Profile
16.8.2 Tiantan Biological Oral Polio Vaccines (OPV) Product Specification
16.8.3 Tiantan Biological Oral Polio Vaccines (OPV) Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Oral Polio Vaccines (OPV) Manufacturing Cost Analysis
17.1 Oral Polio Vaccines (OPV) Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Oral Polio Vaccines (OPV)
17.4 Oral Polio Vaccines (OPV) Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Oral Polio Vaccines (OPV) Distributors List
18.3 Oral Polio Vaccines (OPV) Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Oral Polio Vaccines (OPV) (2021-2026)
20.2 Global Forecasted Revenue of Oral Polio Vaccines (OPV) (2021-2026)
20.3 Global Forecasted Price of Oral Polio Vaccines (OPV) (2015-2026)
20.4 Global Forecasted Production of Oral Polio Vaccines (OPV) by Region (2021-2026)
20.4.1 North America Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.3 Europe Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.7 Africa Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.9 South America Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Oral Polio Vaccines (OPV) Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Oral Polio Vaccines (OPV) by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.2 East Asia Market Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.3 Europe Market Forecasted Consumption of Oral Polio Vaccines (OPV) by Countriy
21.4 South Asia Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.5 Southeast Asia Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.6 Middle East Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.7 Africa Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.8 Oceania Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.9 South America Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
21.10 Rest of the world Forecasted Consumption of Oral Polio Vaccines (OPV) by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer